PR RELEASE valix?Noticed some trends in the PR releases, wondering if they will followLongby TysonHunterPublished 5
VXL.V -- High risk/high reward Coronavirus vaccine developerVXL is the volume leader on TSX-V today on the news of Coronavirus vaccine patent application. +21.74% so far. Likely held down by warrant sellers but could be a serious runner once they are out. $12M mkt cap is cheap compared to other biomed stocks that ran on Coronavirus related news. Very decent float at 89M shares.by wealth_bakeryUpdated 115